Capsaicin-Loaded Melanin Nanoparticles for Long-Lasting Nociceptive-Selective Nerve Blockade.
Xiaosi Li1, Qi Li1, Xinyu Xia2
1Department of Chemical and Biological Engineering, University of Alabama, Tuscaloosa, Alabama 35487, United States.
Langmuir : the ACS Journal of Surfaces and Colloids
|November 14, 2024
Summary
Researchers developed capsaicin-loaded melanin nanoparticles (Cap-MNPs) for improved pain relief. These nanoparticles offer a longer-lasting, selective nerve block without motor function loss or toxicity.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmacology
Background:
- Current local anesthetics like bupivacaine and lidocaine have limited duration and affect both sensory and motor neurons, causing unwanted motor function loss.
- Developing novel drug delivery systems is crucial for targeted and sustained therapeutic effects in pain management.
Purpose of the Study:
- To engineer capsaicin-loaded melanin nanoparticles (Cap-MNPs) to overcome the limitations of conventional local anesthetics.
- To achieve selective sensory nerve blockade with an extended duration of action and minimal toxicity.
Main Methods:
- Encapsulation of capsaicin within melanin nanoparticles (MNPs) utilizing hydrophobic and π-π interactions.
- Characterization of Cap-MNPs for drug loading efficiency, capacity, and in vitro release kinetics.
- Evaluation of Cap-MNPs in a rat sciatic nerve block model for efficacy, duration, and toxicity.
Main Results:
- Cap-MNPs demonstrated high drug loading efficiency (82.99 ± 1.55%) and capacity (67.47 ± 4.24%).
- Sustained capsaicin release from Cap-MNPs exceeded 360 hours.
- A single injection of Cap-MNPs in rats produced a 6-hour sciatic sensory nerve block without local or systemic toxicity.
Conclusions:
- Capsaicin-loaded melanin nanoparticles (Cap-MNPs) provide a promising strategy for selective and long-acting sensory nerve blockade.
- Cap-MNPs offer a potential therapeutic advancement for effective pain management with reduced side effects.
Related Concept Videos
Local Anesthetics: Differential Sensitivity of Nerve Fibers
776
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
776
Nociception
27.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
976
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
976
Local Anesthetics: Mechanism of Action
2.2K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
148
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
148
Analgesia and Pain Management
518
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
518


